Co-Director, Basic Research, Cancer Research Institute Of Northern Alberta
University of Alberta
Edmonton, AB, Canada
Lynne-Marie Postovit is the Sawin-Baldwin Chair in Ovarian Cancer and the Dr. Anthony Noujaim Legacy Oncology Chair as well as an associate professor in the Department of Oncology at the University of Alberta. In April 2014, she was also awarded an Alberta Innovates Health Services Translation Chair in Cancer and later that year she was appointed as the inaugural co-director for basic science at the Cancer Research Institute of Northern Alberta. She completed her PhD at Queen’s University in the area of oxygen sensing and a Post-Doc with Mary Hendrix at Northwestern in the areas of epigenetics, stem cells and cancer progression. Lynne is an expert in the area of women’s cancers, and her research group strives to find new ways to detect cancers earlier and to treat metastatic disease. They uniquely do this by measuring and targeting factors surrounding cancers. These “microenvironmental agents” allow cancer cells to adapt to and survive the harshest of treatments. It is thought that targeting such entities could diminish the ability of cancer cells to evade therapy and spread. In addition to dozens of academic publications, in journals such as Nature Medicine, Nature Reviews Cancer, PNAS and Cancer Research, Dr. Postovit’s work has produced 3 patents; one of which progressed into clinical trials for the treatment of prostate cancer and has led to the development of a start-up company. She currently holds multiple grants from the CIHR and is also supported by the CFI, CRS, ACF, CBCF, Royal Alex Foundation and AIHS. In 2009, Dr. Postovit received the Peter Lougheed/CIHR New Investigator Award, the Canadian Institutes of Health Research’s (CIHR’s) most important career development award, given annually to Canada’s top-ranked new investigator. Finally, in 2012 she was named “a scientist to watch” by the Scientist magazine, an international periodical highlighting breakthroughs in the life sciences.